Bio-Rad Laboratories, Inc. Stock Analysis & AI Score
Bio-Rad Laboratories, Inc. (BIO) has an ST Score of 61.8 (B), driven by its Sentiment (A+) and held back by its Growth (D-). Analysts rate it Buy with a $350.00 price target (-9.7% downside).
Composite rating from 8 factors. Tap a factor to see the metrics behind its grade.
Company Information
| Employees | — |
| CEO | — |
| Sector | Healthcare |
| Industry | Medical - Devices |
| IPO Date | — |
| Website | — |
| Country | — |
| Exchange | NYSE |
SEC Filings
Annual Report (10-K)
| Filing Date | Accepted | Link |
|---|---|---|
| Loading… | ||
Quarterly Report (10-Q)
| Filing Date | Accepted | Link |
|---|---|---|
| Loading… | ||
ST Score
Bio-Rad Laboratories, Inc. (BIO) has an ST Score of 61.8 (B), driven by its Sentiment (A+) and held back by its Growth (D-). Analysts rate it Buy with a $350.00 price target (-9.7% downside).
- Strongest
- SentimentA+
- Weakest
- GrowthD-
All factor grades
- SentimentA+
- ProfitabilityA
- MomentumA
- Financial StrengthB
- ForecastC
- ValuationC-
- GrowthD-
- Piotroski7/9
Contact
BIO stock: frequently asked questions
What is BIO's ST Score?
Bio-Rad Laboratories, Inc. (BIO) has an ST Score of 61.8 (B), on our 0–100 scale where higher is stronger. The ST Score combines eight factor grades — valuation, profitability, financial strength, momentum, growth, forecast, sentiment and Piotroski — into a single A+ to F rating.
Is BIO a buy, hold, or sell?
Analysts rate BIO a Buy, with a price target of $350.00 (-9.7% vs the current price). Our ST Score grades it B (61.8/100). The ST Score is a data-driven signal, not a recommendation.
What are BIO's factor grades?
Valuation C-, Profitability A, Financial Strength B, Momentum A, Growth D-, Forecast C, Sentiment A+.
What is BIO's valuation grade?
Bio-Rad Laboratories, Inc. (BIO) earns a valuation grade of C-, measured against Medical - Devices peers. The valuation factor looks at multiples such as P/E, P/S, P/B, EV/EBITDA and free cash flow yield.
What is BIO's growth grade?
Bio-Rad Laboratories, Inc. (BIO) earns a growth grade of D-, measured against Medical - Devices peers. The growth factor looks at revenue, earnings and cash flow growth over recent quarters and years.
What is BIO's profitability grade?
Bio-Rad Laboratories, Inc. (BIO) earns a profitability grade of A, measured against Medical - Devices peers. The profitability factor looks at margins and returns such as gross margin, net margin, ROE and ROIC.
What is BIO's financial strength grade?
Bio-Rad Laboratories, Inc. (BIO) earns a financial strength grade of B, measured against Medical - Devices peers. The financial strength factor looks at debt levels, liquidity and coverage ratios.
What is the analyst price target for BIO?
The average analyst price target for Bio-Rad Laboratories, Inc. (BIO) is $350.00 from 14 analysts, which is -9.7% versus the recent price of $387.54.
What is BIO's Piotroski score?
Bio-Rad Laboratories, Inc. (BIO) has a Piotroski F-Score of 7 out of 9. The Piotroski score checks nine accounting signals covering profitability, leverage and operating efficiency; scores of 8–9 are considered strong and 0–2 weak.